If the cost of R&D for a new drug really were $43 million…
““If the cost of R&D for a new drug really were $43 million, as Light and Warburton would have it, and the financial and tax advantages so great, why isn't everyone pouring money into the drug industry? Why aren't VC firms lining up to get in on this sweet deal? I mean, $43 million for a drug, you should be able to raise that pretty easily, even in this climate - and then you just stand back as the money gushes into the sky. Don't you?””
About This Quote
This interpretation was drafted with AI assistance. It is one reading of the quote, not the author's own explanation.
The author questions why high R&D costs and incentives don’t attract more investment, suggesting a paradox in the pharma industry.
In simple terms: Drug development seems under‑funded despite profit potential.
Key Takeaway
Investigate hidden barriers to investment.
Themes
investment
pharma economics
R&D costs
venture capital
Mood
skeptical
inquisitive
Type
analytical
critical
When to use this quote
- pharmaceutical funding
- venture capital decisions
- policy debate
Key Concepts
financial incentives
regulatory hurdles
market dynamics
Questions to Reflect On
- What risks deter investors?
- How do regulations affect funding?
A Different Perspective
The quote simplifies complex regulatory and risk factors.